337 related articles for article (PubMed ID: 33297578)
1. Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks.
Unruh C; Van Bavel N; Anikovskiy M; Prenner EJ
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297578
[TBL] [Abstract][Full Text] [Related]
2. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium in Medical Imaging-Usefulness, Toxic Reactions and Possible Countermeasures-A Review.
Blomqvist L; Nordberg GF; Nurchi VM; Aaseth JO
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740867
[TBL] [Abstract][Full Text] [Related]
4. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
Telgmann L; Sperling M; Karst U
Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
[TBL] [Abstract][Full Text] [Related]
5. "Stability" of gadolinium chelates.
Tweedle MF
Br J Radiol; 2007 Jul; 80(955):583-4; author reply 584-5. PubMed ID: 17704319
[No Abstract] [Full Text] [Related]
6. Extracellular gadolinium contrast agents: differences in stability.
Morcos SK
Eur J Radiol; 2008 May; 66(2):175-9. PubMed ID: 18343072
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic systemic fibrosis: more questions and some answers.
Morcos SK; Thomsen HS
Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
[TBL] [Abstract][Full Text] [Related]
8. [Physico-chemical and toxicological profile of gadolinium chelates as contrast agents for magnetic resonance imaging].
Idée JM; Fretellier N; Thurnher MM; Bonnemain B; Corot C
Ann Pharm Fr; 2015 Jul; 73(4):266-76. PubMed ID: 25731664
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium induced effects on mammalian cell motility, adherence and chromatin structure.
Nagy G; Baksa V; Kiss A; Turani M; Banfalvi G
Apoptosis; 2017 Feb; 22(2):188-199. PubMed ID: 27770270
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.
Taupitz M; Stolzenburg N; Ebert M; Schnorr J; Hauptmann R; Kratz H; Hamm B; Wagner S
Contrast Media Mol Imaging; 2013; 8(2):108-16. PubMed ID: 23281283
[TBL] [Abstract][Full Text] [Related]
11. Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
Thakral C; Alhariri J; Abraham JL
Contrast Media Mol Imaging; 2007 Jul; 2(4):199-205. PubMed ID: 17712863
[TBL] [Abstract][Full Text] [Related]
12. Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.
Lu ZR; Mohs AM; Zong Y; Feng Y
Int J Nanomedicine; 2006; 1(1):31-40. PubMed ID: 17722260
[TBL] [Abstract][Full Text] [Related]
13. MRI gadolinium-based contrast agents. Radiologists beware!
Goullé JP; Cattanéo A; Saussereau E; Mahieu L; Guerbet M; Lacroix C
Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
[TBL] [Abstract][Full Text] [Related]
14. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
16. Integration of gadolinium in nanostructure for contrast enhanced-magnetic resonance imaging.
Marasini R; Thanh Nguyen TD; Aryal S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1580. PubMed ID: 31486295
[TBL] [Abstract][Full Text] [Related]
17. Effective mitigation of gadolinium deposition using the bidentate hydroxypyridinone ligand Me-3,2-HOPO.
Sun Q; Wang X; Shi C; Guan J; Chen L; Wang Y; Wang S; Diwu J
Dalton Trans; 2022 Aug; 51(34):13055-13060. PubMed ID: 35971987
[TBL] [Abstract][Full Text] [Related]
18. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
Martinelli J; Fekete M; Tei L; Botta M
Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
Abraham JL; Thakral C
Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
